June 27, 2025

The Download: how to clean up AI data centers, and weight-loss drugs’ side effects

This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. This battery recycling company is now cleaning up AI data centers In a sandy industrial lot outside Reno, Nevada, rows of battery packs that once propelled electric vehicles are now powering a small…

Why these 30 web3 founders are optimistic about 2024

December 15, 2023

About 70% of founders are optimistic about the opportunities for crypto startups in 2024, per a new survey shared exclusively with TechCrunch+.

© 2023 TechCrunch. All rights reserved. For personal use only.

The Download: beyond CRISPR, and OpenAI’s superalignment findings

December 15, 2023
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. Vertex developed a CRISPR cure. It’s already on the hunt for something better. The company that just got approval to sell the first gene-editing treatment in history, for sickle-cell disease, is already looking…

In the fight against Methane, a key GHG, Valley investors have hit upon an unusual target: Cow burps

December 15, 2023

What do iconic Valley investors Zachary Bogue and Chris Sacca have in common? They are both trying to stop cows from burping methane. No, really. And a Sacca investment just raised $20 million to do just that. What gives? With the conclusion of COP28, the global talks on the climate crisis, Methane is going up […]

© 2023 TechCrunch. All rights reserved. For personal use only.

Vertex developed a CRISPR cure. It’s already on the hunt for something better.

December 15, 2023
The company that just got approval to sell the first gene-editing treatment in history, for sickle-cell disease, is already looking for an ordinary drug that could take its place. Vertex Pharmaceuticals has a 50-person team working “to make a pill that doesn’t do gene editing at all,” says David Altshuler, head of research at the…

Decoding Buy or Hold for These 3 Software Stocks

December 15, 2023
The software industry is experiencing a surge in demand driven by rising digitization and a significant transition toward cloud-based solutions. Given this backdrop, let’s decode whether software stocks Palo Alto…

Needle-free covid vaccines are (still) in the works

December 15, 2023
This article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it in your inbox every Thursday, and read articles like this first, sign up here. Covid shots do an admirable job of boosting our immune response enough to protect against serious illness, but they don’t boost immunity in the one spot…